Bionano Genomics: A Belated Update
Back before I can remember -- as in January of this year -- I wrote a piece on the challenging situation of BioNano Genomics. I got an important detail wrong in that piece, missing some important fundraising, but in general from the point-of-view I took I thought it was a decent piece, meant to convey the challenge of a really amazing technology having its original market disappear. Some commenters took strong excepti on to the piece and suggested I had not-so-pure motives for writing it. They're wrong -- but at AGBT I got a chance to learn more about the company's new direction and how I hadn't been looking at things quite appropriately. I should have written it up there, but working on a response to the pandemic started taking over my life and I let time slip away. Preparing crow to be eaten also tends to be procrastinated. But here, finally, is a re-look at the company (and, I drafted this over a month ago and never finishe d -- the procrastination drags on...)I was a bit nervous strolling into the BioNano Genomics booth at Marco Island. Maybe they were the ones so offended by the piece. But no, they actually invited me to come to a morning talk and to chat afterwards, and were completely professional and cordial and made it clear they understood the angle I had taken as a sincere journalistic approach. But not only did I hea r the talk then, but I had gotten a preview the night before in the Twist Suite, which also illustrates a key card B...
Source: Omics! Omics! - Category: Bioinformatics Authors: Keith Robison Source Type: blogs